Stay updated on Pembrolizumab in Advanced Penile Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Penile Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This is a minor maintenance release with no changes to the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-04-16T11:16:44.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Version 3.5.0 was added and version 3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:08:59.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T15:29:05.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Added site revision notice: Revision: v3.4.2. Removed the earlier funding-lapse notice (Revision: v3.4.1) from the page.
    Difference
    0.4%
    Check dated 2026-02-11T02:37:34.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a global notice about a lapse in government funding and NIH Clinical Center operations, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:56:13.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Minor UI and metadata updates include showing the glossary toggle, adding QC-related metadata (Last Update Submitted that Met QC Criteria), No FEAR Act Data, and Revision: v3.4.0, while replacing older labels such as Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T21:15:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Penile Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.